Table 2 Main clinical and laboratory characteristics of the three COVID-19 splenectomised patients.
From: Depletion of circulating IgM memory B cells predicts unfavourable outcome in COVID-19
Patient | #1 | #2 | #3 |
|---|---|---|---|
Age | 83 | 53 | 55 |
Sex | F | M | M |
Age at splenectomy (years) | 58 | 41 | 29 |
Reason for splenectomy | Trauma | Trauma | Trauma |
Length of stay (days) | 12 | 18 | 9 |
Infection during stay | No | UTI (E. coli) | No |
Total lymphocytes (n/µl) | 400 | 1588 | 1522 |
Total B cells (n/µl) | 69.2 | 492.4 | 156.8 |
Memory B cells (n/µl) | 3.2 | 43.8 | 24.8 |
IgM memory B cells (n/µl) | 1.1 | 12.8 | 5.02 |
Switched memory B cells (n/µl) | 2.5 | 27.1 | 14.6 |
Platelet-to-lymphocyte ratio | 0.9 | 0.1 | 0.3 |
Neutrophil-to-lymphocyte ratio | 22.9 | 6.4 | 2.6 |
Lactate dehydrogenase (mU/ml) | 408 | 222 | 265 |
C reactive protein (mg/dl) | 15.3 | 10.3 | 5.3 |
Pitted red cells (%) | 6.4 | 10.2 | 12.4 |
Platelets (× 103/µl) | 374 | 266 | 544 |
Outcome | Discharged | Discharged | Dead |
Venous thromboembolism | No | No | No |
